News|Articles|March 4, 2025

Ophthalmology Month in Review: February 2025

The February 2025 month in review covers 7 key pipeline updates in ophthalmology, including regulatory approvals, label expansions, and topline trial results.

February saw significant regulatory advancements and clinical trial milestones in ophthalmology, signaling progress in treating retinal diseases and corneal disorders. The US Food and Drug Administration (FDA) approved the first continuous delivery treatment for diabetic macular edema (DME), while an intravitreal insert met its Phase 2 endpoints, showing promise in reducing the treatment burden for DME patients.